TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance

U.S. Markets closed

Teva Pharmaceutical Industries Limited (TEVA)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
33.47-0.63 (-1.85%)
At close: 4:03PM EST

33.59 0.12 (0.36%)
After hours: 7:52PM EST

People also watch
MYLNVSGILDAMGNABT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close34.10
Open33.98
Bid0.00 x
Ask0.00 x
Day's Range33.46 - 34.09
52 Week Range33.46 - 64.31
Volume7,498,760
Avg. Volume10,346,206
Market Cap33.97B
Beta0.47
PE Ratio (TTM)22.36
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.36 (4.03%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Secures FDA Approval For Vantreal ER
    Insider Monkey8 hours ago

    Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Secures FDA Approval For Vantreal ER

    Patients with severe pain that demands long-term, around-the-clock treatment now have a new medication to try. They will now be able to use Vantreal ER (hydrocodone bitartrate), which has gained the approval of the US Food and Drug Administration (FDA). The drug from Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is suitable for daily management of […]

  • Teva's (TEVA) Pain Drug Vantrela ER Receives FDA Approval
    Zacks13 hours ago

    Teva's (TEVA) Pain Drug Vantrela ER Receives FDA Approval

    Teva Pharmaceutical Industries Ltd. (TEVA) announced that the FDA has approved Vantrela ER for the treatment of pain which is severe enough to require daily, around-the-clock, long-term opioid treatment.

  • Investopediayesterday

    Teva's Pain Drug Gets Approved By The FDA

    Shares of Teva are up slightly today after the company announced the FDA approved its pain management drug.